PRODUCT LITERATURE

Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients

---

Post-marketing surveillance studies (PMSS) of medications are often mandated by authorities, provide crucial insights for health services and are useful to define the clinical profiles of therapies. Desloratadine, a non-sedating, second-generation H1-receptor antagonist, is an effective and well-tolerated treatment for chronic idiopathic urticaria (CIU).

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Deslotine

Specific Detail Info

JEADV 2009, 23, 292–299

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment